BioNTech Jumps After Raising Its Covid Vaccine Goal to 2.5 Billion Doses By

<iframe src=”//″ width=”250″ height=”250″ scrolling=”no” border=”0″ marginwidth=”0″ style=”border:none;” frameborder=”0″></iframe>

© Reuters

By Dhirendra Tripathi – Shares of BioNTech (NASDAQ:) jumped 9% in Tuesday’s trade after the company said it was going to make more Covid-19 vaccine shots than it had planned earlier.

The biotech company now aims to make 2.5 billion doses in 2021, compared to its previous target of 2.3 billion to 2.4 billion doses. Additional measures and discussions with potential partners to further expand the manufacturing capacity and network are ongoing, the company said in a filing.

The good news for the company and the world doesn’t end here. Quoting the German company’s co-founder and CEO Ugur Sahin, Bloomberg said a version of the Covid-19 shot that can be stored in refrigerators will be ready within months.

BioNTech announced its December quarter financial results, recognizing €270.5 million ($318 million) as the first commercial Covid-19 vaccine revenue for the full year 2020.

As of March 2021, the company said it had delivered more than 200 million doses of its vaccine to more than 65 countries and regions together with its partners that include Pfizer (NYSE:).



Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.